Testing the feasibility of Low Intensity Frequency Ultrasound to modulate locomotor control

Summary

This study uses special sound waves, called low intensity frequency ultrasound to gently affect small areas of the brain for a short time. There is no surgery involved, and it is safe to use. By watching how a person moves during tasks before and after the sound waves are used, we can learn how the brain helps control movement. In the future, this research might help create better treatments for conditions like Parkinson’s disease.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 70

Accepts healthy participants: Yes

Inclusion criteria:

1. Healthy adults, 18 years +, right-handed
2. No history of seizures or heart problems
3. No ear injuries
4. No alcohol or drug dependency
5. Not taking any prescription medicines
6. Able and willing to complete an MRI scan
7. Able to speak and understand English

Exclusion criteria:

1.Health problems with the body, heart, or lungs that make using a mini pedal bike unsafe
2. A history of seizures
3. Past ear injuries
4. Metal in the body or fear of small spaces that could make an MRI unsafe
5. Not able to speak or understand English
6. Currently misusing alcohol or drugs
7. Currently pregnant
8. On prescription medication

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Can contact the coordinator Cecilia Ruether

Principal investigator:

Patrick Whelan

Clinical trial:

No

REB-ID:

REB25-1601